These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1288040)

  • 1. [Digestive lesions related to N.S.A.I.D. (epidemiology and prevention)].
    Florent C
    Acta Gastroenterol Belg; 1992; 55(5-6):423-9. PubMed ID: 1288040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of commonly used NSAID's on gastric mucosa. A clinico-endoscopic and histopathological study.
    Misra R; Pandey H; Chandra M; Chandra M; Agarwal PK; Pandeya SN
    J Assoc Physicians India; 1990 Dec; 38(12):913-5. PubMed ID: 2096127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Asymptomatic and symptomatic gastroduodenal patients affected by rheumatic disease treated with non-steroidal anti-inflammatory drugs.
    Magarò M; Altomonte L; Zoli A; Mirone L; Berchicci MC; Tricerri A; Corvino G
    Panminerva Med; 1989; 31(1):16-8. PubMed ID: 2786181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Underutilization of preventive strategies in patients receiving NSAIDs.
    Sturkenboom MC; Burke TA; Dieleman JP; Tangelder MJ; Lee F; Goldstein JL
    Rheumatology (Oxford); 2003 Nov; 42 Suppl 3():iii23-31. PubMed ID: 14585915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonsteroidal anti-inflammatory drugs: add an anti-ulcer drug for patients at high risk only. Always limit the dose and duration of treatment with NSAIDs.
    Prescrire Int; 2011 Sep; 20(119):216-9. PubMed ID: 21954519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastrointestinal lesions during treatment with non-steroidal anti-inflammatory drugs (NSAIDs).
    Festen HP
    Neth J Med; 1989 Dec; 35(5-6):327-33. PubMed ID: 2699655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of NSAID-gastropathy.
    Ardizzone S; Bianchi Porro G
    Ital J Gastroenterol; 1996 Dec; 28 Suppl 4():33-6. PubMed ID: 9032581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Eradication of Helicobacter pylori in peptic ulcer and chronic gastritis. A randomized clinical trial].
    Rodríguez Hernández H; Sánchez Anguiano LF; Quiñones E
    Rev Gastroenterol Mex; 1998; 63(1):21-7. PubMed ID: 10068745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonsteroidal antiinflammatory drugs and the gastrointestinal tract.
    Hirschowitz BI
    Gastroenterologist; 1994 Sep; 2(3):207-23. PubMed ID: 7987619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Current state of treatment and prevention of gastroduodenal side effects of non-steroidal antirheumatic drugs].
    Bolten W
    Leber Magen Darm; 1991 Sep; 21(5):193-4, 196. PubMed ID: 1758234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of proton pump inhibitors in NSAID-associated gastropathy and upper gastrointestinal symptoms.
    Laine L
    Rev Gastroenterol Disord; 2003; 3 Suppl 4():S30-9. PubMed ID: 14671512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastroprotective therapy and risk of gastrointestinal ulcers: risk reduction by COX-2 therapy.
    Wolfe F; Anderson J; Burke TA; Arguelles LM; Pettitt D
    J Rheumatol; 2002 Mar; 29(3):467-73. PubMed ID: 11908558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proton-pump inhibitors reduce the risk of uncomplicated peptic ulcer in elderly either acute or chronic users of aspirin/non-steroidal anti-inflammatory drugs.
    Pilotto A; Franceschi M; Leandro G; Paris F; Cascavilla L; Longo MG; Niro V; Andriulli A; Scarcelli C; Di Mario F
    Aliment Pharmacol Ther; 2004 Nov; 20(10):1091-7. PubMed ID: 15569111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prevention of NSAID induced gastroduodenal ulcers].
    Hansen JM; Bytzer P
    Ugeskr Laeger; 2001 Oct; 163(44):6103-5. PubMed ID: 11715151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prevention of chronic NSAID induced upper gastrointestinal toxicity: a Cochrane collaboration metaanalysis of randomized controlled trials.
    Rostom A; Wells G; Tugwell P; Welch V; Dubé C; McGowan J
    J Rheumatol; 2000 Sep; 27(9):2203-14. PubMed ID: 10990235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Misoprostol prevents NSAID-induced gastroduodenal lesions in patients with osteoarthritis and rheumatoid arthritis.
    Saggioro A; Alvisi V; Blasi A; Dobrilla G; Fioravanti A; Marcolongo R
    Ital J Gastroenterol; 1991; 23(3):119-23. PubMed ID: 1742504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention and treatment of ulcers induced by nonsteroidal anti-inflammatory drugs: an update.
    Dajani EZ; Agrawal NM
    J Physiol Pharmacol; 1995 Mar; 46(1):3-16. PubMed ID: 7599335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention and treatment of non-steroidal anti-inflammatory drug-induced gastro-duodenal damage: rationale for the use of antisecretory compounds.
    Scarpignato C; Pelosini I
    Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S63-72. PubMed ID: 10379472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of nonsteroidal anti-inflammatory drug-induced gastropathy.
    Miller DR
    Clin Pharm; 1992 Aug; 11(8):690-704. PubMed ID: 1511542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ulcer healing with ranitidine and antacids despite continued therapy with non-steroidal anti-rheumatic drugs].
    Stock KP; Bach GL
    Z Rheumatol; 1988; 47(3):177-81. PubMed ID: 3213266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.